Does Rallies show Form 4 insider transactions for ALNY?

Yes. Rallies tracks ALNY insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is ALNY research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ALNY. It does not provide personalized investment advice.

ALNY (Alnylam Pharmaceuticals) Stock Analysis - Insider Trades

Alnylam Pharmaceuticals (ALNY) is a publicly traded Healthcare sector company. As of May 20, 2026, ALNY trades at $296.14 with a market cap of $38.22B and a P/E ratio of 122.46. ALNY moved +1.41% today. Year to date, ALNY is -26.46%; over the trailing twelve months it is +0.84%. Its 52-week range spans $205.87 to $495.55. Analyst consensus is strong buy with an average price target of $452.73. Rallies surfaces ALNY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading ALNY stock inside the company?

Recent ALNY insider activity includes McLaughlin Melissa sold 56, McLaughlin Melissa sold 909, McLaughlin Melissa sold 829, McLaughlin Melissa sold 293, and McLaughlin Melissa sold 199. Rallies tracks insider transaction dates, shares, prices, and estimated values.

ALNY Key Metrics

Key financial metrics for ALNY
Metric	Value
Price	$296.14
Market Cap	$38.22B
P/E Ratio	122.46
EPS	$2.39
Dividend Yield	0.00%
52-Week High	$495.55
52-Week Low	$205.87
Volume	603.28K
Avg Volume	0
Revenue (TTM)	$3.71B
Net Income	$313.75M
Gross Margin	81.77%

Recent ALNY Insider Trades

McLaughlin Melissa sold 56 (~$17.93K) on Apr 6, 2026.
McLaughlin Melissa sold 909 (~$299.75K) on Apr 6, 2026.
McLaughlin Melissa sold 829 (~$273.95K) on Apr 6, 2026.
McLaughlin Melissa sold 293 (~$97.24K) on Apr 6, 2026.
McLaughlin Melissa sold 199 (~$66.45K) on Apr 6, 2026.

Latest ALNY News

Alnylam slips after Q1 results despite $1.04B product revenue and guidance reiteration — May 1, 2026
Alnylam jumps as Q1 profit and record $1.17B revenue top expectations — Apr 30, 2026
Alnylam slides as traders de-risk into April 30 Q1 results, valuation worries linger — Apr 24, 2026
Alnylam drops as Jefferies downgrade spotlights valuation after big run — Apr 19, 2026
Alnylam slides as valuation worries persist after Jefferies downgrade and target cut — Apr 18, 2026

ALNY Analyst Consensus

18 analysts cover ALNY: 0 strong buy, 15 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $452.73.

Common questions about ALNY

Who is trading ALNY stock inside the company?: Recent ALNY insider activity includes McLaughlin Melissa sold 56, McLaughlin Melissa sold 909, McLaughlin Melissa sold 829, McLaughlin Melissa sold 293, and McLaughlin Melissa sold 199. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for ALNY?: Yes. Rallies tracks ALNY insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is ALNY research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ALNY. It does not provide personalized investment advice.